OpenURL Connection Search

Select item for more details and to access through your institution.

Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands.
Published in:
Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 43, doi. 10.1016/j.clgc.2021.10.008
By:
- Kuppen, Malou C. P.;
- Westgeest, Hans M.;
- van den Eertwegh, Alfons J. M.;
- van Moorselaar, Reindert J. A.;
- van Oort, Inge M.;
- Tascilar, Metin;
- Mehra, Niven;
- Lavalaye, Jules;
- Somford, Diederik M.;
- Aben, Katja K. H.;
- Bergman, Andre M.;
- de Wit, Ronald;
- van den Bergh, A. C. M. (Fons);
- Uyl-de Groot, Carin A.;
- Gerritsen, Winald R.
Publication type:
Article
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.
Published in:
2017
By:
- van der Hiel, Bernies;
- Haanen, John B. A. G.;
- Stokkel, Marcel P. M.;
- Peeper, Daniel S.;
- Jimenez, Connie R.;
- Beijnen, Jos H.;
- van de Wiel, Bart A.;
- Boellaard, Ronald;
- van den Eertwegh, Alfons J. M.;
- REPOSIT study group
Publication type:
journal article
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Published in:
2023
By:
- Blankenstein, Stephanie A.;
- Bonenkamp, Johannes J.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- Blank, Christian U.;
- Blokx, Willeke A. M.;
- Boers-Sonderen, Marye J.;
- van den Eertwegh, Alfons J. M.;
- Franken, Margreet G.;
- de Groot, Jan Willem B.;
- Haanen, John B. A. G.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen W.;
- van Not, Olivier J.;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Suijkerbuijk, Karijn P. M.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- Westgeest, Hans M.
Publication type:
Abstract
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 573, doi. 10.1245/s10434-022-12600-2
By:
- Blankenstein, Stephanie A.;
- Bonenkamp, Johannes J.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- Blank, Christian U.;
- Blokx, Willeke A. M.;
- Boers-Sonderen, Marye J.;
- van den Eertwegh, Alfons J. M.;
- Franken, Margreet G.;
- de Groot, Jan Willem B.;
- Haanen, John B. A. G.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen W.;
- van Not, Olivier J.;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Suijkerbuijk, Karijn P. M.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- Westgeest, Hans M.
Publication type:
Article
IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation.
Published in:
PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070237
By:
- Lindenberg, Jelle J.;
- Oosterhoff, Dinja;
- Sombroek, Claudia C.;
- Lougheed, Sinéad M.;
- Hooijberg, Erik;
- Stam, Anita G. M.;
- Santegoets, Saskia J. A. M.;
- Tijssen, Henk J.;
- Buter, Jan;
- Pinedo, Herbert M.;
- van den Eertwegh, Alfons J. M.;
- Scheper, Rik J.;
- Koenen, Hans J. P. M.;
- van de Ven, Rieneke;
- de Gruijl, Tanja D.
Publication type:
Article
Dual-Phase PET-CT to Differentiate [18F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer.
Published in:
PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048430
By:
- Oprea-Lager, Daniela E.;
- Vincent, Andrew D.;
- van Moorselaar, Reindert J. A.;
- Gerritsen, Winald R.;
- Van den Eertwegh, Alfons J. M.;
- Eriksson, Jonas;
- Boellaard, Ronald;
- Hoekstra, Otto S.
Publication type:
Article
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Published in:
2019
By:
- Koster, Bas D.;
- Santegoets, Saskia J. A. M.;
- Harting, Jorien;
- Baars, Arnold;
- van Ham, S. Marieke;
- Scheper, Rik J.;
- Hooijberg, Erik;
- de Gruijl, Tanja D.;
- van den Eertwegh, Alfons J. M.
Publication type:
Correction Notice
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 6, p. 1025, doi. 10.1007/s00262-019-02320-0
By:
- Koster, Bas D.;
- Santegoets, Saskia J. A. M.;
- Harting, Jorien;
- Baars, Arnold;
- van Ham, S. Marieke;
- Scheper, Rik J.;
- Hooijberg, Erik;
- de Gruijl, Tanja D.;
- van den Eertwegh, Alfons J. M.
Publication type:
Article
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.
Published in:
Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1569, doi. 10.1007/s00262-008-0536-z
By:
- De Gruijl, Tanja D.;
- van den Eertwegh, Alfons J. M.;
- Pinedo, Herbert M.;
- Scheper, Rik J.
Publication type:
Article
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.
Published in:
Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1480, doi. 10.1007/s00262-006-0142-x
By:
- Santegoets, Saskia J. A. M.;
- Schreurs, Marco W. J.;
- Masterson, Allan J.;
- Ying Poi Liu;
- Goletz, Steffen;
- Baumeister, Hans;
- Kueter, Esther W. M.;
- Lougheed, Sinéad M.;
- van den Eertwegh, Alfons J. M.;
- Scheper, Rik J.;
- Hooijberg, Erik;
- de Gruijl, Tanja D.
Publication type:
Article
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61150-y
By:
- Leek, Lindsay V. M.;
- Notohardjo, Jessica C. L.;
- de Joode, Karlijn;
- Velker, Eline L.;
- Haanen, John B. A. G.;
- Suijkerbuijk, Karijn P. M.;
- Aarts, Maureen J. B.;
- de Groot, Jan Willem B.;
- Kapiteijn, Ellen;
- van den Berkmortel, Franchette W. P. J.;
- Westgeest, Hans M.;
- de Gruijl, Tanja D.;
- Retel, Valesca P.;
- Cuppen, Edwin;
- van der Veldt, Astrid A. M.;
- Labots, Mariette;
- Voest, Emile E.;
- van de Haar, Joris;
- van den Eertwegh, Alfons J. M.
Publication type:
Article
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
Published in:
Cancers, 2020, v. 12, n. 5, p. 1176, doi. 10.3390/cancers12051176
By:
- Blankenstein, Stephanie A.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- Boers-Sonderen, Marye J.;
- van den Eertwegh, Alfons J. M.;
- Franken, Margreet G.;
- de Groot, Jan Willem B.;
- Haanen, John B. A. G.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Suijkerbuijk, Karijn P. M.;
- ten Tije, Albert J.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- Wouters, Michel W. J. M.;
- van Akkooi, Alexander C. J.
Publication type:
Article
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs.
Published in:
Cancers, 2020, v. 12, n. 4, p. 1003, doi. 10.3390/cancers12041003
By:
- Leeneman, Brenda;
- Uyl-de Groot, Carin A.;
- Aarts, Maureen J. B.;
- van Akkooi, Alexander C. J.;
- van den Berkmortel, Franchette W. P. J.;
- van den Eertwegh, Alfons J. M.;
- de Groot, Jan Willem B.;
- Herbschleb, Karin H.;
- van der Hoeven, Jacobus J. M.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Suijkerbuijk, Karijn P. M.;
- ten Tije, Albert J.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- Wouters, Michel W. J. M.;
- Haanen, John B. A. G.;
- Franken, Margreet G.
Publication type:
Article
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.
Published in:
NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00641-7
By:
- Gogas, Helen;
- Ravimohan, Shruthi;
- Datta, Antara;
- Chhibber, Aparna;
- Couselo, Eva Muñoz;
- Diab, Adi;
- Pereira, Caio;
- Quéreux, Gaëlle;
- Sandhu, Shahneen;
- Curti, Brendan;
- Khushalani, Nikhil I.;
- Taylor, Matthew H.;
- Daniels, Gregory A.;
- Spreafico, Anna;
- Meniawy, Tarek;
- Van Den Eertwegh, Alfons J. M.;
- Sun, Yongliang;
- Arriaga, Yull;
- Zhou, Ming;
- Long, Georgina V.
Publication type:
Article
Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer.
Published in:
EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0531-8
By:
- Cysouw, Matthijs C. F.;
- Kramer, Gerbrand M.;
- Heijtel, Dennis;
- Schuit, Robert C.;
- Morris, Michael J.;
- van den Eertwegh, Alfons J. M.;
- Voortman, Jens;
- Hoekstra, Otto S.;
- Oprea-Lager, Daniela E.;
- Boellaard, Ronald
Publication type:
Article
Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nationwide study.
Published in:
International Journal of Cancer, 2024, v. 155, n. 8, p. 1455, doi. 10.1002/ijc.35060
By:
- Bloem, Manja;
- van Not, Olivier J.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- Blank, Christian U.;
- Blokx, Willeke A. M.;
- Boers‐Sonderen, Marye J.;
- Bonenkamp, Johannes J.;
- de Groot, Jan‐Willem B.;
- Haanen, John B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen W.;
- de Meza, Melissa M.;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Stevense‐den Boer, Marion A. M.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- van den Eertwegh, Alfons J. M.;
- Suijkerbuijk, Karijn P. M.
Publication type:
Article
Adjuvant treatment of in‐transit melanoma: Narrowing the knowledge gap left by clinical trials.
Published in:
International Journal of Cancer, 2023, v. 153, n. 2, p. 389, doi. 10.1002/ijc.34485
By:
- de Meza, Melissa M.;
- Blokx, Willeke A. M.;
- Bonenkamp, Han J.;
- Blank, Cristian U.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- Boers‐Sonderen, Marye J.;
- de Groot, Jan Willem B.;
- Haanen, John B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen W.;
- van Not, Olivier J.;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Stevense‐Den Boer, Marion A.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- van den Eertwegh, Alfons J. M.;
- Suijkerbuijk, Karijn P. M.;
- Wouters, Michel W. J. M.
Publication type:
Article
Discontinuation of anti‐PD‐1 monotherapy in advanced melanoma—Outcomes of daily clinical practice.
Published in:
International Journal of Cancer, 2022, v. 150, n. 2, p. 317, doi. 10.1002/ijc.33800
By:
- van Zeijl, Michiel C. T.;
- van den Eertwegh, Alfons J. M.;
- Wouters, Michel W. J. M.;
- de Wreede, Liesbeth C.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- de Groot, Jan‐Willem B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Suijkerbuijk, Karijn P. M.;
- ten Tije, Albert J.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- van der Hoeven, Jacobus J. M.;
- Haanen, John B. A. G.
Publication type:
Article
Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation.
Published in:
Science Immunology, 2022, v. 7, n. 73, p. 1, doi. 10.1126/sciimmunol.abn8097
By:
- van Pul, Kim M.;
- Notohardjo, Jessica C. L.;
- Fransen, Marieke F.;
- Koster, Bas D.;
- Stam, Anita G. M.;
- Chondronasiou, Dafni;
- Lougheed, Sinéad M.;
- Bakker, Joyce;
- Kandiah, Vinitha;
- van den Tol, M. Petrousjka;
- Jooss, Karin;
- Vuylsteke, Ronald J. C. L. M.;
- van den Eertwegh, Alfons J. M.;
- de Gruijl, Tanja D.
Publication type:
Article
CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity.
Published in:
Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.697840
By:
- Affandi, Alsya J.;
- Olesek, Katarzyna;
- Grabowska, Joanna;
- Nijen Twilhaar, Maarten K.;
- Rodríguez, Ernesto;
- Saris, Anno;
- Zwart, Eline S.;
- Nossent, Esther J.;
- Kalay, Hakan;
- de Kok, Michael;
- Kazemier, Geert;
- Stöckl, Johannes;
- van den Eertwegh, Alfons J. M.;
- de Gruijl, Tanja D.;
- Garcia-Vallejo, Juan J.;
- Storm, Gert;
- van Kooyk, Yvette;
- den Haan, Joke M. M.
Publication type:
Article
Simplified Methods for Quantification of 18F‐DCFPyL Uptake in Patients with Prostate Cancer.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.227520
By:
- Jansen, Bernard H. E.;
- Yaqub, Maqsood;
- Voortman, Jens;
- Cysouw, Matthijs C. F.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Kramer, Gerbrand M.;
- van den Eertwegh, Alfons J. M.;
- Schwarte, Lothar A.;
- Harry Hendrikse, N.;
- Vis, André N.;
- van Moorselaar, Reindert J. A.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- Oprea‐Lager, D. E.
Publication type:
Article
Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies.
Published in:
Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1642, doi. 10.2967/jnumed.116.173831
By:
- Cysouw, Matthijs C. F.;
- Kramer, Gerbrand Maria;
- Hoekstra, Otto S.;
- Frings, Virginie;
- de Langen, Adrianus Johannes;
- Smit, Egbert F.;
- van den Eertwegh, Alfons J. M.;
- Oprea-Lager, Daniela E.;
- Boellaard, Ronald
Publication type:
Article
Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
Published in:
Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 721, doi. 10.2967/jnumed.115.167692
By:
- Oprea-Lager, Daniela E.;
- Kramer, Gem;
- van de Ven, Peter M.;
- van den Eertwegh, Alfons J. M.;
- van Moorselaar, Reindert J. A.;
- Schober, Patrick;
- Hoekstra, Otto S.;
- Lammertsma, Adriaan A.;
- Boellaard, Ronald
Publication type:
Article
Quantification of 18F-Fluorocholine Kinetics in Patients with Prostate Cancer.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 3, p. 365, doi. 10.2967/jnumed.114.148007
By:
- Verwer, Eline E.;
- Oprea-Lager, Daniela E.;
- van den Eertwegh, Alfons J. M.;
- van Moorselaar, Reindert J. A.;
- Windhorst, Albert D.;
- Schwarte, Lothar A.;
- Hendrikse, N. Harry;
- Schuit, Robert C.;
- Hoekstra, Otto S.;
- Lammertsma, Adriaan A.;
- Boellaard, Ronald
Publication type:
Article
Long-Term Survival in Patients With Advanced Melanoma.
Published in:
JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
By:
- van Not, Olivier J.;
- van den Eertwegh, Alfons J. M.;
- Jalving, Hilde;
- Bloem, Manja;
- Haanen, John B.;
- van Rijn, Rozemarijn S.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- Blank, Christian U.;
- Boers-Sonderen, Marye J.;
- de Groot J. W. B., Jan Willem;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Leeneman, Brenda;
- D., Piersma;
- Stevense-den Boer, Marion;
- van der Veldt, Astrid A. M.;
- Vreugdenhil G., Gerard;
- Wouters, Michel W. J. M.;
- Blokx, Willeke A. M.
Publication type:
Article
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
Published in:
Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-37
By:
- Santegoets, Saskia JAM;
- Turksma, Annelies W.;
- Suhoski, Megan M.;
- Stam, Anita G. M.;
- Albelda, Steve M.;
- Hooijberg, Erik;
- Scheper, Rik J.;
- van den Eertwegh, Alfons J. M.;
- Gerritsen, Winald R.;
- Powell Jr., Daniel J.;
- June, Carl H.;
- de Gruijl, Tanja D.
Publication type:
Article
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
Published in:
2013
By:
- Santegoets, Saskia Jam;
- Turksma, Annelies W;
- Suhoski, Megan M;
- Stam, Anita Gm;
- Albelda, Steve M;
- Hooijberg, Erik;
- Scheper, Rik J;
- van den Eertwegh, Alfons Jm;
- Gerritsen, Winald R;
- Powell Jr, Daniel J;
- June, Carl H;
- de Gruijl, Tanja D;
- Santegoets, Saskia J A M;
- Stam, Anita G M;
- van den Eertwegh, Alfons J M;
- Powell, Daniel J Jr
Publication type:
journal article
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment.
Published in:
Health & Quality of Life Outcomes, 2012, v. 10, n. 1, p. 66, doi. 10.1186/1477-7525-10-66
By:
- Revicki, Dennis A.;
- van den Eertwegh, Alfons J. M.;
- Lorigan, Paul;
- Lebbe, Celeste;
- Linette, Gerald;
- Ottensmeier, Christian H.;
- Safikhani, Shima;
- Messina, Marianne;
- Hoos, Axel;
- Wagner, Samuel;
- Kotapati, Srividya
Publication type:
Article
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
Published in:
2013
By:
- Kelderman, Sander;
- van der Kooij, Monique K.;
- van den Eertwegh, Alfons J. M.;
- Soetekouw, Patricia M. M. B.;
- Jansen, Rob L. H.;
- van den Brom, Rob R. H.;
- Hospers, Geke A. P.;
- Haanen, John B. A. G.;
- Kapiteijn, Ellen;
- Blank, Christian U.
Publication type:
Letter
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)
Published in:
2013
By:
- Kelderman, Sander;
- van der Kooij, Monique K.;
- van den Eertwegh, Alfons J. M.;
- Soetekouw, Patricia M. M. B.;
- Jansen, Rob L. H.;
- van den Brom, Rob R. H.;
- Hospers, Geke A. P.;
- Haanen, John B. A. G.;
- Kapiteijn, Ellen;
- Blank, Christian U.
Publication type:
Journal Article
The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.
Published in:
Cancer Informatics, 2016, n. 15, p. 115, doi. 10.4137/CIN.S38122
By:
- van der Meijde, Elisabeth;
- van den Eertwegh, Alfons J. M.;
- Linn, Sabine C.;
- Meijer, Gerrit A.;
- Fijneman, Remond J. A.;
- Coupé, Veerle M. H.
Publication type:
Article
Targeted therapies in renal cell cancer: recent developments in imaging.
Published in:
2010
By:
- Veldt, Astrid;
- Meijerink, Martijn;
- Eertwegh, Alfons;
- Boven, Epie;
- van der Veldt, Astrid A M;
- Meijerink, Martijn R;
- van den Eertwegh, Alfons J M
Publication type:
journal article
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.
Published in:
Cancer (0008543X), 2014, v. 120, n. 7, p. 968, doi. 10.1002/cncr.28518
By:
- Badrising, Sushil;
- van der Noort, Vincent;
- van Oort, Inge M.;
- van den Berg, H. Pieter;
- Los, Maartje;
- Hamberg, Paul;
- Coenen, Jules L.;
- van den Eertwegh, Alfons J. M.;
- de Jong, Igle J.;
- Kerver, Emile D.;
- van Tinteren, Harm;
- Bergman, Andries M.
Publication type:
Article
Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma.
Published in:
Cancer (0008543X), 2009, v. 115, n. 17, p. 3944, doi. 10.1002/cncr.24473
By:
- Weber, Jeffrey S.;
- Zarour, Hassan;
- Redman, Bruce;
- Trefzer, Uwe;
- O'Day, Steven;
- Van den Eertwegh, Alfons J. M.;
- Marshall, Ernest;
- Wagner, Stefan
Publication type:
Article
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Published in:
Cancer (0008543X), 2024, v. 130, n. 9, p. 1673, doi. 10.1002/cncr.35178
By:
- Van Not, Olivier J.;
- van den Eertwegh, Alfons J. M.;
- Haanen, John B.;
- van Rijn, Rozemarijn S.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- Blank, Christian U.;
- Boers‐Sonderen, Marye J.;
- de Groot, Jan Willem W. B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Bloem, Manja;
- Piersma, Djura;
- Stevense‐den Boer, Marion;
- Verheijden, Rik J.;
- van der Veldt, Astrid A. M.;
- Wouters, Michel W. J. M.;
- Blokx, Willeke A. M.;
- Suijkerbuijk, Karijn P. M.
Publication type:
Article
A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems.
Published in:
2015
By:
- Oprea-Lager, Daniela;
- Yaqub, Maqsood;
- Pieters, Indra;
- Reinhard, Rinze;
- Moorselaar, Reindert;
- Eertwegh, Alfons;
- Hoekstra, Otto;
- Lammertsma, Adriaan;
- Boellaard, Ronald;
- Oprea-Lager, Daniela E;
- Pieters, Indra C;
- van Moorselaar, Reindert J A;
- van den Eertwegh, Alfons J M;
- Hoekstra, Otto S;
- Lammertsma, Adriaan A
Publication type:
journal article
[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.
Published in:
2015
By:
- Oprea-Lager, Daniela E;
- van Kanten, Mitchell P;
- van Moorselaar, Reindert J A;
- van den Eertwegh, Alfons J M;
- van de Ven, Peter M;
- Bijnsdorp, Irene V;
- Hoekstra, Otto S;
- Geldof, Albert A
Publication type:
journal article
Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophages revisited.
Published in:
European Journal of Immunology, 1992, v. 22, n. 3, p. 719, doi. 10.1002/eji.1830220315
By:
- van den Eertwegh, Alfons J. M.;
- Laman, Jon D.;
- Schellekens, Marc M.;
- Boersma, Wim J. A.;
- Claassen, Eric
Publication type:
Article

Found: 38

Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands.

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.

ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation.

Dual-Phase PET-CT to Differentiate [<sup>18</sup>F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer.

Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.

Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs.

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

Sensitivity of <sup>18</sup>F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer.

Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nationwide study.

Adjuvant treatment of in‐transit melanoma: Narrowing the knowledge gap left by clinical trials.

Discontinuation of anti‐PD‐1 monotherapy in advanced melanoma—Outcomes of daily clinical practice.

Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T<sub>reg</sub> reduction and effector T cell activation.

CD169 Defines Activated CD14<sup>+</sup> Monocytes With Enhanced CD8<sup>+</sup> T Cell Activation Capacity.

Simplified Methods for Quantification of <sup>18</sup>F‐DCFPyL Uptake in Patients with Prostate Cancer.

Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies.

Repeatability of Quantitative <sup>18</sup>F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.

Quantification of <sup>18</sup>F-Fluorocholine Kinetics in Patients with Prostate Cancer.

Long-Term Survival in Patients With Advanced Melanoma.

IL-21 promotes the expansion of CD27<sup>+</sup> CD28<sup>+</sup> tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.

IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment.

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.

Targeted therapies in renal cell cancer: recent developments in imaging.

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma.

BRAF/MEK inhibitor rechallenge in advanced melanoma patients.

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems.

[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.

Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophages revisited.